CS logo
small CS logo
Christchurch Hospital (Canterbury District Health Board)

Christchurch, New Zealand
Warehouse in Christchurch
4 Rapide Way, Yaldhurst, Christchurch 8042

About Christchurch Hospital (Canterbury District Health Board)


"This location is the Supply Department for Canterbury DHB, providing medical supplies to health facilities, it does not provide health services to the general public, please see the Canterbury DHB website for health information."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Christchurch Hospital (Canterbury District Health Board)


During the past decade, Christchurch Hospital (Canterbury District Health Board) conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Christchurch Hospital (Canterbury District Health Board)" #1 collaborator was "Astellas Pharma Inc" with 2 trials as a collaborator and "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at Christchurch Hospital (Canterbury District Health Board)


According to Clinical.Site data, the most researched conditions in "Christchurch Hospital (Canterbury District Health Board)" are "Respiratory Tract Infection" (2 trials), "Cancer of the Prostate" (1 trials), "Facial Angiofibroma" (1 trials), "Hemophilia A" (1 trials) and "Non Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Christchurch Hospital (Canterbury District Health Board)" in a lesser frequency.

Clinical Trials Intervention Types at Christchurch Hospital (Canterbury District Health Board)


Most popular intervention types in "Christchurch Hospital (Canterbury District Health Board)" are "Drug" (5 trials), "Biological" (3 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Best Available Therapy" (1 trials), "CP-690,500 5 mg" (1 trials), "CP-690,550 10 mg" (1 trials) and "Conventionally Fractionated Radiotherapy (ConRT)" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Christchurch Hospital (Canterbury District Health Board)


The vast majority of trials in "Christchurch Hospital (Canterbury District Health Board)" are 4 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Clinical Trials Status at Christchurch Hospital (Canterbury District Health Board)


Currently, there are NaN active trials in "Christchurch Hospital (Canterbury District Health Board)". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Christchurch Hospital (Canterbury District Health Board), undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Christchurch Hospital (Canterbury District Health Board), 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Departments of Christchurch Hospital (Canterbury District Health Board)


Christchurch Hospital (Canterbury District Health Board) has several departments that took part in Clinical trials: "Canterbury Health Laboratories; Haematology" - 3 trials, "Christchurch Hospital; Dept of Oncology" - 3 trials